Lyell Immunopharma Announces $80 Million Private Placement

Filing content

Lyell Immunopharma entered into a securities purchase agreement to issue 7,428,040 shares of common stock at $10.77 per share to institutional investors. The private placement is expected to generate approximately $80 million in gross proceeds and is scheduled to close on or about November 4, 2026.